Aprogen Biologics Inc. (003060.KS) KSC

583.00

+1(+0.17%)

Updated at December 05 01:35PM

Currency In KRW

Valuation

Market Cap182.99B
Enterprise Value324.7B
P/E Ratio-0.62
PEG Ratio0.03
Price/Sales Ratio1.69
Price/Book Ratio0.43
Enterprise/Revenue3.94
Enterprise/EBITDA-1.71

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-2.71
Operating Margin-0.92

Management Effectiveness

Return On Assets-0.31
Return On Equity-0.52

Income Statement

Revenue67.38B
Revenue/Share345.24
Gross Profit-7.58B
EBITDA-51.33B
Net Income-104.98B
Diluted EPS-835

Balance Sheet

Total Cash29.18B
Total Cash/Share147.44
Total Debt179.8B
Total Debt/Equity0.67
Current Ratio0.71
Book Value Per Share1,710.35

Price History

52-Week Change-42.56
52-Week High887
52-Week Low520
Moving Average 50 Days582.76
Moving Average 200 Days654.08

Statistics

Average Volume605,406
Shares Outstanding197.57M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateApril 16, 2024